Carolyn E. Behrendt

Also affiliated with City of Hope, Beckman Research Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Predicting hyperglycemia among patients receiving alpelisib plus fulvestrant for metastatic breast cancer.”.

Predicting hyperglycemia among patients receiving alpelisib plus fulvestrant for metastatic breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1060

N/A

0DataRank · unranked

2 citations

Carolyn E. Behrendt, Susan E. Yost, Niki Patel, Raynald Samoa, Daphne Stewart +6 more

Inflammation-related proteins as biomarkers of treatment-related behavioral symptoms: A longitudinal study of breast cancer patients and age-matched controls

Brain Behavior & Immunity - Health(2023)10.1016/j.bbih.2023.100670

N/A

0DataRank · unranked

4 citations

Elizabeth C. Breen, I. Benjamin Paz, Laura Kruper, Joanne Mortimer, F. Lennie Wong +4 more

HER2-targeted antibody–drug conjugates for breast cancer: ancestry and dose adjustment for thrombocytopenia

Breast Cancer(2023)10.1007/s12282-023-01473-2

N/A

0DataRank · unranked

7 citations

Carolyn E. Behrendt, Saro Kasparian, Tina Nguyen, Mina S. Sedrak, Sayeh Lavasani +7 more

Order of patient entry and outcomes in phase II clinical trials: A meta-analysis of individual patient data

Contemporary Clinical Trials(2023)10.1016/j.cct.2023.107083

N/A

0DataRank · unranked

0 citations

Miguel A. Villalona‐Calero, Edward M. Newman, Paul Frankel, Carolyn E. Behrendt